- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 7, 2025 | 13.36M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $208.23M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $330.4M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.08B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.17B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.4B |
| Total Assets | Q1 2025 · Mar 31, 2024 | $2.29B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 13.79M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $1.05M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $4.09M |
| Capex restated | Q1 2025 · Mar 31, 2024 | $3.49M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $9.83M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $229.49M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $229.81M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.52 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.53 |
| Net Income | Q1 2025 · Mar 31, 2024 | $7.15M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $27.74M |